Provided by Tiger Trade Technology Pte. Ltd.

LifeMD Inc.

3.05
+0.01500.50%
Volume:1.01M
Turnover:3.11M
Market Cap:147.26M
PE:-35.14
High:3.16
Open:3.10
Low:3.01
Close:3.03
52wk High:7.32
52wk Low:2.56
Shares:48.36M
Float Shares:39.02M
Volume Ratio:1.83
T/O Rate:2.58%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.0866
EPS(LYR):0.2492
ROE:-515.90%
ROA:-18.92%
PB:18.49
PE(LYR):12.22

Loading ...

LifeMD declares USD 0.55 quarterly dividend on 8.875% Series A preferred stock

Reuters
·
Jun 23

Press Release: LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock

Dow Jones
·
Jun 23

LifeMD partners with Halozyme unit Antares to launch XYOSTED telehealth self-pay program in July 2026

Reuters
·
Jun 22

LifeMD - Xyosted Self-Pay Program to Launch in July 2026 in 37 States

THOMSON REUTERS
·
Jun 22

LifeMD Announces Exclusive Collaboration to Launch Direct-to-Patient Self-Pay Program for Xyosted® (Testosterone Enanthate) Injection

THOMSON REUTERS
·
Jun 22

LifeMD - Xyosted Self-Pay Program Priced at About $249 per Month

THOMSON REUTERS
·
Jun 22

LifeMD files Form 3 for CTO Sripad Umesh, reports no beneficial ownership holdings

Reuters
·
Jun 04

LifeMD Names Umesh Sripad as Chief Technology Officer

MT Newswires Live
·
Jun 01

LifeMD names Umesh Sripad as chief technology officer

Reuters
·
Jun 01

LifeMD Appoints Umesh Sripad as Chief Technology Officer

THOMSON REUTERS
·
Jun 01

Analysts Are Bullish on These Healthcare Stocks: LifeMD (LFMD), Corbus Pharmaceuticals (CRBP)

TIPRANKS
·
May 27

LifeMD Price Target Maintained With a $10.00/Share by HC Wainwright & Co.

Dow Jones
·
May 27

LifeMD to present at LD Micro Invitational conference

Reuters
·
May 15

LifeMD (LFMD) Gets a Buy from BTIG

TIPRANKS
·
May 07

LifeMD Q1 revenue beats estimates on record telehealth subscriber additons

Reuters
·
May 07

LifeMD Q1 EPS $(0.20) Beats $(0.23) Estimate, Sales $50.163M Beat $48.842M Estimate

Benzinga Earnings
·
May 07

BRIEF-LifeMD Q1 Adjusted EBITDA USD -4.5 Million Vs. IBES Estimate USD -4.66 Million

Reuters
·
May 07

LifeMD Outlook Q2 Adj Ebitda of Negative $2 Million to Positive $1 Million

THOMSON REUTERS
·
May 07

LifeMD Inc - Affirms FY2026 Revenue Guidance $220 Mln-$230 Mln; Adj Ebitda $12 Mln-$17 Mln

THOMSON REUTERS
·
May 07

LifeMD Inc expected to post a loss of 22 cents a share - Earnings Preview

Reuters
·
May 05